BANK OF NOVA SCOTIA - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 170 filers reported holding HAEMONETICS CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF NOVA SCOTIA ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2020$5,165,000
+1281.0%
59,200
+453.8%
0.01%
+600.0%
Q1 2016$374,000
+8.4%
10,6900.0%0.00%0.0%
Q4 2015$345,0000.0%10,6900.0%0.00%0.0%
Q3 2015$345,000
+28.7%
10,690
+64.5%
0.00%
+100.0%
Q2 2015$268,000
-7.9%
6,5000.0%0.00%0.0%
Q1 2015$291,0006,5000.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2015
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders